ZYUS Life Sciences Statistics
Total Valuation
TSXV:ZYUS has a market cap or net worth of CAD 50.80 million. The enterprise value is 63.24 million.
Market Cap | 50.80M |
Enterprise Value | 63.24M |
Important Dates
The next estimated earnings date is Friday, November 28, 2025.
Earnings Date | Nov 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TSXV:ZYUS has 78.15 million shares outstanding. The number of shares has increased by 5.21% in one year.
Current Share Class | 78.15M |
Shares Outstanding | 78.15M |
Shares Change (YoY) | +5.21% |
Shares Change (QoQ) | +1.69% |
Owned by Insiders (%) | 51.63% |
Owned by Institutions (%) | 0.20% |
Float | 35.81M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 105.17 |
PB Ratio | -5.19 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.86 |
EV / Sales | 130.94 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -6.51 |
Financial Position
The company has a current ratio of 0.13
Current Ratio | 0.13 |
Quick Ratio | 0.07 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -1.34 |
Interest Coverage | -11.99 |
Financial Efficiency
Return on equity (ROE) is -1,184.75% and return on invested capital (ROIC) is -66.38%.
Return on Equity (ROE) | -1,184.75% |
Return on Assets (ROA) | -40.34% |
Return on Invested Capital (ROIC) | -66.38% |
Return on Capital Employed (ROCE) | 807.20% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.02 |
Inventory Turnover | 1.11 |
Taxes
Income Tax | -2.05M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.69% in the last 52 weeks. The beta is 0.95, so TSXV:ZYUS's price volatility has been similar to the market average.
Beta (5Y) | 0.95 |
52-Week Price Change | -21.69% |
50-Day Moving Average | 0.69 |
200-Day Moving Average | 0.78 |
Relative Strength Index (RSI) | 46.93 |
Average Volume (20 Days) | 10,629 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSXV:ZYUS had revenue of CAD 483,000 and -34.04 million in losses. Loss per share was -0.46.
Revenue | 483,000 |
Gross Profit | -952,000 |
Operating Income | -15.35M |
Pretax Income | -36.09M |
Net Income | -34.04M |
EBITDA | -12.93M |
EBIT | -15.35M |
Loss Per Share | -0.46 |
Balance Sheet
The company has 559,000 in cash and 13.01 million in debt, giving a net cash position of -12.45 million or -0.16 per share.
Cash & Cash Equivalents | 559,000 |
Total Debt | 13.01M |
Net Cash | -12.45M |
Net Cash Per Share | -0.16 |
Equity (Book Value) | -9.78M |
Book Value Per Share | -0.13 |
Working Capital | -11.88M |
Cash Flow
In the last 12 months, operating cash flow was -9.70 million and capital expenditures -12,000, giving a free cash flow of -9.72 million.
Operating Cash Flow | -9.70M |
Capital Expenditures | -12,000 |
Free Cash Flow | -9.72M |
FCF Per Share | -0.12 |
Margins
Gross Margin | -197.10% |
Operating Margin | -3,178.67% |
Pretax Margin | -7,472.46% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TSXV:ZYUS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -5.21% |
Shareholder Yield | n/a |
Earnings Yield | -67.01% |
FCF Yield | -19.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TSXV:ZYUS has an Altman Z-Score of -25.43 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -25.43 |
Piotroski F-Score | 3 |